Literature DB >> 20683695

Diagnostic pitfall on the histological spectrum of adult-onset renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.

Naoto Kuroda1, Kazunobu Katto, Yukichi Tanaka, Tadanori Yamaguchi, Kaori Inoue, Masahiko Ohara, Keiko Mizuno, Ondrej Hes, Michal Michal, Gang-Hong Lee.   

Abstract

Renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusion recently has been found. In this article, we demonstrate an unusual features of such a case. A 73-year-old Japanese woman presented with macroscopic hematuria. The imaging examinations disclosed the renal tumor. Histological examination showed the finding of ASPL-TFE3 RCC, which was characterized by papillary, alveolar, or solid growth of voluminous cell with clear and eosinophilic cells, and stromal psammoma body and hyaline nodules. Additionally, shrunken nuclei, thick cell border, and perinuclear clearing characteristic of chromophobe renal cell carcinoma were observed in the alveolar growth area and the transitional zone between stromal hyalinization, and osseous metaplasia was identified. Immunohistochemically, nuclei of tumorous cell were diffusely positive for TFE3. A RT-PCR study revealed the ASPL-TFE3 chimeric transcript. Finally, pathologists should recognize that the histology of RCC associated with Xp11.2 translocation/TFE3 gene fusion may focally resemble that of chromophobe RCC, but TFE3 immunohistochemistry and molecular genetic study may be helpful in the differential diagnosis. Moreover, osseous metaplasia as well as psammoma bodies should be added to the histological spectrum of the stromal change in RCC associated with Xp11.2 translocations/TFE3 gene fusions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683695     DOI: 10.1007/s00795-008-0423-x

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  21 in total

1.  Variant chromophobe renal cell carcinoma.

Authors:  R J Cohen; S Weinstein; T Robertson; L N Sellner; H J Dawkins; J E McNeal
Journal:  Arch Pathol Lab Med       Date:  2000-06       Impact factor: 5.534

2.  Renal oncocytoma: a clinicopathologic study of 70 cases.

Authors:  B Perez-Ordonez; G Hamed; S Campbell; R A Erlandson; P Russo; P B Gaudin; V E Reuter
Journal:  Am J Surg Pathol       Date:  1997-08       Impact factor: 6.394

3.  Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.

Authors:  P Argani; C R Antonescu; P B Illei; M Y Lui; C F Timmons; R Newbury; V E Reuter; A J Garvin; A R Perez-Atayde; J A Fletcher; J B Beckwith; J A Bridge; M Ladanyi
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Metanephric adenoma. Clinicopathological study of fifty patients.

Authors:  C J Davis; J H Barton; I A Sesterhenn; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1995-10       Impact factor: 6.394

5.  PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).

Authors:  Pedram Argani; Cristina R Antonescu; Jérôme Couturier; Jean-Christophe Fournet; Raf Sciot; Maria Debiec-Rychter; Brian Hutchinson; Victor E Reuter; Lilliane Boccon-Gibod; Charles Timmons; Naiel Hafez; Marc Ladanyi
Journal:  Am J Surg Pathol       Date:  2002-12       Impact factor: 6.394

Review 6.  Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: report of a case and review of the literature.

Authors:  Malcolm Schinstine; Armando C Filie; Carlos Torres-Cabala; Andrea Abati; W Marston Linehan; Maria Merino
Journal:  Diagn Cytopathol       Date:  2006-11       Impact factor: 1.582

7.  Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma.

Authors:  Matteo Brunelli; John N Eble; Shaobo Zhang; Guido Martignoni; Brett Delahunt; Liang Cheng
Journal:  Mod Pathol       Date:  2005-02       Impact factor: 7.842

8.  Chromophobe renal cell carcinoma: useful diagnostic application of imprint cytology and fluorescence in situ hybridization of chromosomes 10 and 21 in two cases of typical and eosinophilic variants.

Authors:  Naoto Kuroda; Kazunobu Katto; Tadanori Yamaguchi; Takako Kawada; Yoshiaki Imamura; Ondrej Hes; Michal Michal; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

9.  Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.

Authors:  Pedram Argani; Priti Lal; Brian Hutchinson; Man Yee Lui; Victor E Reuter; Marc Ladanyi
Journal:  Am J Surg Pathol       Date:  2003-06       Impact factor: 6.394

10.  Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults.

Authors:  Paul N Meyer; Joseph I Clark; Robert C Flanigan; Maria M Picken
Journal:  Am J Clin Pathol       Date:  2007-07       Impact factor: 2.493

View more
  6 in total

1.  TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human Disease.

Authors:  Masaya Baba; Mitsuko Furuya; Takanobu Motoshima; Martin Lang; Shintaro Funasaki; Wenjuan Ma; Hong-Wei Sun; Hisashi Hasumi; Ying Huang; Ikuma Kato; Tsuyoshi Kadomatsu; Yorifumi Satou; Nicole Morris; Baktiar O Karim; Lilia Ileva; Joseph D Kalen; Luh Ade Wilan Krisna; Yukiko Hasumi; Aiko Sugiyama; Ryoma Kurahashi; Koshiro Nishimoto; Masafumi Oyama; Yoji Nagashima; Naoto Kuroda; Kimi Araki; Masatoshi Eto; Masahiro Yao; Tomomi Kamba; Toshio Suda; Yuichi Oike; Laura S Schmidt; W Marston Linehan
Journal:  Mol Cancer Res       Date:  2019-05-01       Impact factor: 5.852

2.  Cardiopulmonary bypass-assisted surgery for the treatment of Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma with a tumor thrombus within the inferior vena cava: A case report.

Authors:  Guanchen Zhu; Xuefeng Qiu; Xianchen Chen; Guangxiang Liu; Gutian Zhang; Weidong Gan; Hongqian Guo
Journal:  Oncol Lett       Date:  2015-09-24       Impact factor: 2.967

3.  Re-evaluation of histological type by immunohistochemical and genetic study of transcription factors (TFE3 and TFEB) of VHL gene mutation-negative clear cell renal cell carcinoma and other special types of renal tumor.

Authors:  Naoto Kuroda; Chiaki Kawada; Kenji Tamura; Makoto Hiroi; Ondrej Hes; Michal Michal; Yukari Wada; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-03-23       Impact factor: 2.309

4.  Xp11 translocation renal cell carcinoma in adults: a clinicopathological and comparative genomic hybridization study.

Authors:  Hong Zou; Xueling Kang; Li-Juan Pang; Wenhao Hu; Jin Zhao; Yan Qi; Jianming Hu; Chunxia Liu; Hongan Li; Weihua Liang; Xianglin Yuan; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

5.  TFE3-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour.

Authors:  Alessandro Pietro Aldera; Amsha Ramburan; Jeff John
Journal:  Urol Case Rep       Date:  2022-02-25

6.  MiT translocation renal cell carcinomas: two subgroups of tumours with translocations involving 6p21 [t (6; 11)] and Xp11.2 [t (X;1 or X or 17)].

Authors:  Milan Hora; Tomáš Urge; Ivan Trávníček; Jiří Ferda; Zdeněk Chudáček; Tomáš Vaněček; Michal Michal; Fredrik Petersson; Naoto Kuroda; Ondřej Hes
Journal:  Springerplus       Date:  2014-05-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.